These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol. Ricardo SD; Bertram JF; Ryan GB Exp Nephrol; 1995; 3(5):270-9. PubMed ID: 7583048 [TBL] [Abstract][Full Text] [Related]
17. Differences in puromycin aminonucleoside nephrosis in two rat strains. Grond J; Muller EW; van Goor H; Weening JJ; Elema JD Kidney Int; 1988 Feb; 33(2):524-9. PubMed ID: 3361753 [TBL] [Abstract][Full Text] [Related]
18. Studies on antinephritic effect of TJ-8014, syo-saiko-to-kyo-shyokyo-ka-ouren-bukuryou (5): Effects on puromycin aminonucleoside nephrosis and its mechanisms. Hattori T; Ito M; Suzuki Y Jpn J Pharmacol; 1991 Aug; 56(4):465-73. PubMed ID: 1744988 [TBL] [Abstract][Full Text] [Related]
19. Altered localization of protamine-heparin complexes in aminonucleoside nephrosis. Seiler MW; Hoyer JR; Krueger TE Lab Invest; 1980 Jul; 43(1):9-17. PubMed ID: 6993788 [No Abstract] [Full Text] [Related]
20. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis. Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]